Dr Vivek Muthu qualified in medicine from Oxford and holds a first-class degree in neurophysiology from Cambridge. He worked at a number of teaching hospitals, including London’s Queen Square and the Hammersmith Hospitals, before joining the British Medical Journal, where he helped to develop and lead a team examining the value of drugs and devices. Vivek went on to found Bazian, a company dedicated to developing and servicing the needs of the emerging paradigm of value-based health internationally, focusing on the application of analytics and evidence to deliver high quality, safe, cost-effective care. He sold Bazian to The Economist Group, becoming global MD of healthcare at the Economist Intelligence Unit. Vivek now continues to advise the Economist Group, and is a non-executive in a number of healthcare companies. He works with the European Bank for Reconstruction and Development, focusing on improving healthcare provision in transitional Eurasian economies, and is also on the steering committee for All.Can, an international, multi-stakeholder initiative to improve outcomes for cancer patients. Vivek regularly chairs and speaks at C-suite and ministerial multi-stakeholder summits, round tables and advisory boards globally, on behalf of both The Economist, industry, policy-makers, NGOs and third sector participants in healthcare. The common theme is how to optimise innovation and patient and population health outcomes.